| 000 | 00000nam 2200000za 4500 |
| 001 | 9.518086 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20200330174054 |
|---|
| 007 | ta |
|---|
| 008 | 150406|1990||||xxc||||| f|0| 0 eng d |
|---|
| 020 | |a0-660-55699-X |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 041 | |aeng |
|---|
| 041 | |afre |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH42-2/30-1990 |
|---|
| 110 | 1 |aCanada.|bHealth and Welfare Canada. |bHealth Protection Branch. |
|---|
| 245 | 10|aChemistry and manufacturing: new drugs |
|---|
| 260 | |aOttawa - Ontario : |bHealth and Welfare Canada. |c1990. |
|---|
| 490 | 1 |aDrugs Directorate guidelines |
|---|
| 500 | |a"This guideline applies to submissions filed with the Bureau of Human Prescription Drugs, the Bureau of Nonprescription Drugs, and the Bureau of Pharmaceutical Surveillance."--Introduction. |
|---|
| 520 | 3 |aThis guideline applies to submissions filed with the Bureau of Human Prescription Drugs, the Bureau of Nonprescription Drugs, and the Bureau of Pharmaceutical Surveillance.--Introduction |
|---|
| 546 | |aBilingual |
|---|
| 563 | |aLoose-leaf |
|---|
| 590 | |a91-08|b1991-02-22 |
|---|
| 690 | 07|aDrug laws|2gcpds |
|---|
| 690 | 07|aDrugs|2gcpds |
|---|
| 690 | 07|aPharmaceutical industry|2gcpds |
|---|
| 776 | 0#|tChemistry and manufacturing |w(CaOODSP)9.808371 |
|---|
| 792 | |tChimie et fabrication: drogues nouvelles |efre|w(CaOODSP)9.518087 |
|---|
| 830 | #0|aDrugs Directorate guidelines.|w(CaOODSP)9.509398 |
|---|